Mayo Clinic researchers helped clarify a growing concern about the link between diabetes treatments and heart attack with the first large study showing that sulfonylureas do not reduce diabetic patients’ heart attack survival rates.
Read More »Secondary Failure of Glucose Control With Metformin, Sulfonylurea, or TZD’s Monotherapy
Which drugs are the ones to sustain good control, the longest?
Read More »Chromium Improves Glycemic Control When Sulfonylurea Is Insufficient
Chromium picolinate (CrPic) supplementation improves glycemic control in patients with type 2 diabetes not adequately controlled while taking sulfonylurea, according to the results of a randomized, double-blind study.
Read More »Type 2 Diabetes Poorly Controlled With Sulfonylurea Improved by Adding Inhaled I
Patients with type 2 diabetes receiving poor control while taking sulfonylurea improve more by adding inhaled insulin vs metformin, according to the results of an open-label, randomized study,
Read More »Sulfonylureas and Insulin Tied to Cancer Deaths in Diabetics
There appears to be an association between use of sulfonylureas or insulin and an increased risk of cancer in patients with type 2 diabetes, compared with patients treated with metformin,
Read More »Sulfonylureas Linked to Heart Deaths
There is more evidence that sulfonylurea drugs, a mainstay for glucose control in type 2 diabetes for decades, increase the risk of mortality from cardiac events.
Read More »Metformin Safer Than Sulfonylureas in Patients With Diabetes and Heart Failure
Studies showed that mono therapy of metformin had 85% fewer deaths and hospitalizations then sulfonylurea.
Read More »Enhancing the Effects of Sulfonylureas when Administered with an ACE Inhibitor
ACE inhibitors may cause a temporary increase of the insulin sensitivity, which leads to an increased risk of hypoglycemia.
Read More »Sulfonylureas Only Transiently Improve Glycemic Control
Although the addition of sulfonylureas to metformin therapy improves glycemic control in type 2 diabetics, deterioration may resume in as little 6 months’
Read More »Glycemic Control Deteriorates After Sulfonylureas Added to Metformin
After 6 months deterioration of glycemic control resumes following the addition of SUs to MF.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.